# Aesica Pharmaceuticals GmbH – FDA Inspection, Aug 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/d6a6b8a4-3554-44f8-9ad9-9207b154e97e
Source feed: FDA_Inspections

> FDA inspection 1277716 of Aesica Pharmaceuticals GmbH, August 31, 2023. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277716
- Company Name: Aesica Pharmaceuticals GmbH
- Inspection Date: 2023-08-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1105950 - 2019-08-30
- [FDA Inspection 994783 - 2016-12-02](https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/3df675b2-3eea-44d0-834f-97f0db529daa)
- [FDA Inspection 887354 - 2014-06-20](https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/f6df76d7-b881-4945-8a88-53c7310b1cf1)
- FDA Inspection 759166 - 2011-11-08

Company: https://www.keypedia.com/companies/aesica-pharmaceuticals-gmbh/84c48ef1-0bd9-41c7-b955-9bb5b443909a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c